Association of programmed death ligand ‐1 (PD‐L1) expression with treatment outcomes in patients with BRAF mutation‐positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenib

Pigment Cell&Melanoma Research, EarlyView.
Source: Pigment Cell Research - Category: Cytology Source Type: research